
MA191 is a FLT3 PROTAC degrader. MA191 abrogates FLT3 ингибитор resistance from rebound activation of mitogen-activated kinases. MA191 mediates rapid FLT3-ITD degradation through a mechanism requiring VHL, neddylation, and BIM. MA191 reduces FLT3-ITD levels before inducing apoptosis. MA191 halts AML клетка proliferation in Danio rerio. MA191 can be used for the study of acute myeloid leukemia (AML).
MA191 is a FLT3 PROTAC degrader. MA191 abrogates FLT3 inhibitor resistance from rebound activation of mitogen-activated kinases. MA191 mediates rapid FLT3-ITD degradation through a mechanism requiring VHL, neddylation, and BIM. MA191 reduces FLT3-ITD levels before inducing apoptosis. MA191 halts AML cell proliferation in Danio rerio. MA191 can be used for the study of acute myeloid leukemia (AML).
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.